Table 3.
Association between ALDH1 and ABCG2 expression and clinicopathological parameters
|
Pathological
data |
Patients number |
ALDH1
|
ABCG2
|
||||
|---|---|---|---|---|---|---|---|
| High expression | Low expression | P-value | High expression | Low expression | P-value | ||
| Age of patient | |||||||
|
≤50 years
>50 years |
17 25 |
11 (65%) 17 (68%) |
6 (35%) 8 (32%) |
0.82 | 9 (53%) 14 (56%) |
8 (47%) 11 (44%) |
0.84 |
| Gender | |||||||
|
Women
Men |
23 19 |
14 (61%) 12 (63%) |
9 (39%) 7 (37%) |
0.87 | 10 (43%) 6 26%) |
13 (57%) 13 (74%) |
0.42 |
| Tumor size | |||||||
|
T1
T2 T3 T4 |
8 20 10 4 |
3 (38%) 12 (60%) 8 (80%) 4 (100%) |
5 (62%) 8 (40%) 2 (20%) Not detected |
0.11 | 2 (25%) 11 (55%) 7 (70%) 4 (75%) |
6 (75%) 9 (45%) 3 (30%) 1 (25%) |
0.16 |
| Tumor stage | |||||||
|
Stage I
Stage II Stage III |
10 19 13 |
3 (30%) 13 (68%) 11(85%) |
7(70%) 6(32%) 2(15%) |
0.01 * | 4 (40%) 14 (74%) 11 (84%) |
6 (60%) 5 (28%) 2 (26%) |
0.025* |
| Lymph node metastasis | |||||||
|
Positive
Negative |
10 32 |
9 (90%) 21 (66%) |
1 (10%) 11 (34%) | 0.13 | 8 (80%) 17 53%) |
2 (20%) 15 (47%) |
0.13 |
*
Statistically significant (P <0.05)